The drugmakers developing the vaccine candidates now in the final stage of clinical testing — Pfizer, Moderna, AstraZeneca and Johnson & Johnson — all told Business Insider they plan to test their vaccines in children, but none gave an estimated timeline of when a vaccine could become available for children.
Moderna shared its plans to begin a pediatric trial with Business Insider, saying it hopes to get one underway by the end of 2020, pending regulatory approval.
“Right now I’m pretty worried that we won’t have a vaccine available for kids by the start of next school year,” Evan Anderson, MD, an Atlanta pediatrician, told The New York Times.
More articles on pharmacy:
Novartis sells $2.1B in bonds to increase access to its drugs in disadvantaged countries
FDA proposes change to rule on off-label drug use
Gilead settles kickback allegations for $97M
